R15K, HIV-1 Inhibitory Peptide, 5mg
£337.39
Delivery: 2 weeks
SKU
CLP0104-5mg
P18IIIB, derived from the V3 loop of HIV-1 IIIB gp120 efficiently blocked HIV-1 IIIB infection of several T-cell lines and of normal human T cells. RIQRGPGRAFVTIGK also blocked syncytium formation in human cells. Moreover, it was capable of inducing HIV-1 specific cytotoxic T lymphocyte responses that could effectively kill virus-infected cells and could thus find several therapeutic applications.
P18IIIB, derived from the V3 loop of HIV-1 IIIB gp120 efficiently blocked HIV-1 IIIB infection of several T-cell lines and of normal human T cells. RIQRGPGRAFVTIGK also blocked syncytium formation in human cells. Moreover, it was capable of inducing HIV-1 specific cytotoxic T lymphocyte responses that could effectively kill virus-infected cells and could thus find several therapeutic applications.
- Size: 5mg
- Purity: ≥95%
- CAS Number: No.114991-28-5
- Molecular Formula: C73H126N26O18
- Molecular Weight: 1655.97
- Physical State: Lyophilized powder
- Storage: Store at -20℃.(Avoid freeze/thaw cycles)
- Brand: Saint Michael
- Catalogue No.: CLP0104-5mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review